False Claims Act, Whistleblower
Department of Justice Office of Public Affairs FOR IMMEDIATE RELEASE Thursday, October 25, 2012 Government Alleges Company Improperly Marketed Three Drugs Connecticut-based Boehringer Ingelheim Pharmaceuticals Inc. has agreed to pay $95 million to resolve allegations...